Celtex Therapeutics
Oct 22, 2021 12:00 PM
Paul Newhouse - Celtex
Celtex Therapeutics


Paul Newhouse, MPH

Assistant Vice President of Client Services at Celltex Therapeutics

Paul Newhouse leads Celltex’s Client Services department, responsible for educating interested candidates about stem cell banking and therapy, facilitating medical reviews of their individual cases, and assisting new clients throughout the entire stem cell banking and therapy process. 

Paul holds a Bachelor of Science in Nutrition, Exercise and Human Sciences from the University of Nebraska, and a Master of Public Health in Healthcare Management from the University of Texas Health Science Center – Houston.

About Celltex:

Celltex Therapeutics is a Houston-based biotechnology company specializing in banking one’s own mesenchymal stem cells, often called MSCs, used to unlock the natural regeneration and repair properties already within the body. 

Established in 2011, Celltex has North America’s largest repository of autologous (one’s own) adipose (fat)-derived MSCs for clinical use in its cGMP FDA-compliant laboratory in Houston. 

Through Celltex’s proprietary technology, a single, small sample of fat tissue can be used to create a pure and powerful bank of your stem cells that can be used as needed throughout your lifetime. 

MSCs have been proven to help with a variety of health conditions, including autoimmune, neurodegenerative, and degenerative conditions as well as those looking to manage inflammation or injury recovery to maintain their quality of life.